MetaCap

Achieve Life Sciences Earnings

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 26, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.19

Achieve Life Sciences earnings summary

Achieve Life Sciences is scheduled to report Sep/2026 earnings on Nov 26, 2026, with analysts expecting EPS of $-0.19. In its most recent report on Nov 19, 2026 (Sep/2026), QUIT posted EPS of $-0.28 versus the $-0.19 consensus estimate, a negative surprise of 47.4%. Achieve Life Sciences beat the consensus EPS estimate in 0 of the last 2 quarters, with a median surprise of -43.7%.

Summary generated from market data by MetaCap's automated system. Methodology

QUIT earnings history

Achieve Life Sciences reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 19, 2026$-0.19$-0.28-47.4%—
Nov 12, 2026$-0.20$-0.28-40.0%-12.0%
Aug 11, 2026—$-0.80——
May 12, 2026—$-0.19——
Mar 24, 2026—$-0.23——
Nov 6, 2025—$-0.28——
Aug 7, 2025—$-0.37——
May 13, 2025—$-0.37——
Mar 11, 2025—$-0.37——
Nov 7, 2024—$-0.36——
Aug 13, 2024—$-0.25——
May 9, 2024—$-0.26——
Mar 28, 2024—$-0.23——
Nov 9, 2023—$-0.34——
Aug 14, 2023—$-0.43——
May 9, 2023—$-0.50——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related